Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Biogen
Biotech
Moderna
Topics

Advertisement

Biogen

Share

Top Latest Popular

🐣 SPRING OFFER! Go ad free with NewsNow Essentials at just £2.99/m!

🐣 SPRING OFFER! Stay informed ad free with NewsNow Essentials at just £2.99 a month!

EULAR 26 hears of treatment advances in lupus pharmaphorum 5d

pharmaphorum 5d

Johnson and Johnson Biotech

Biogen's base is declining — But 8 pipeline readouts could flip the story Benzinga 1d

Benzinga 1d

Apellis Biotech

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA PMLiVE 4d

PMLiVE 4d

Advertisement

Advertisement

Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD? Zacks 16:02 Fri, 29 May

Zacks 16:02 Fri, 29 May

Alzheimer's Pharma

Biogen and Denali discontinue Parkinson’s candidate BIIB122 after Phase IIb LUMA study miss Manufacturing Chemist 08:07 Mon, 25 May

Manufacturing Chemist 08:07 Mon, 25 May

Biogen patent suit targets somerset’s copy of Spinraza therapy Bloomberg Law 21:36 Thu, 21 May

Bloomberg Law 21:36 Thu, 21 May

Advertisement

Advertisement

Latest

Yesterday

Biogen To End Investors' Alzheimer's Drug Case For $18.9M Law360 23:33 Mon, 08 Jun

Biogen's Base Is Declining — But 8 Pipeline Readouts Could Flip The Story Benzinga 17:19 Mon, 08 Jun

This Biogen Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday Benzinga 15:01 Mon, 08 Jun

Friday

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA PMLiVE 13:11 Fri, 05 Jun

Biogen’s salanersen gains FDA breakthrough therapy designation for SMA Pharmaceutical Technology 10:20 Fri, 05 Jun

BIIB Investors Have Opportunity to Join Biogen Inc. Fraud Investigation with the Schall Law Firm Business Wire (Press Release) 02:07 Fri, 05 Jun

Thursday

Fnih Names Recipients of the 2026 Charles A. Sanders, MD, Partnership Award Business Wire (Press Release) 13:02 Thu, 04 Jun

EULAR 26 hears of treatment advances in lupus pharmaphorum 12:46 Thu, 04 Jun

Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy Biogen (Press Release) 12:37 Thu, 04 Jun

Biogen And UCB Present Positive Phoenycs go Data For Dzp In Treating Lupus RTT News 11:40 Thu, 04 Jun

Advertisement

Advertisement

Advertisement

About our Biogen News

Biogen is an American multinational biotechnology company that specialises in treatment of neurological diseases.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna